학술논문
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology May 2021 9(5):293-303
Subject
Language
ISSN
2213-8587